Health Care: Drugs

PDL BioPharma Inc (PDLI: NASDAQ)

$2.46 n/a | n/a%
06/22/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 2.46
52 Week High 3.77
52 Week Low 1.93
Avg. Daily Vol. (Mil) 1.83
Beta (3 year) 0.67
Share Related Items
Mkt Cap (Mil) 396.02
Shares Out (Mil) 160.98
Float (Mil) 158.16
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 56.00
Financial Strength
Quick Ratio 1.90
Current Ratio 2.00
LT Debt/ Equity 0.15
Total Debt / Equity 0.31
Valuation Ratios
Price Earnings 27.30
Price/Sales 2.48
Price/Book 0.52
Price/Cash Flow 9.10
Per Share Data
Earnings 0.09
Sales 0.99
Book Value 4.71
Cash Flow 0.27
Business Summary
PDL BioPharma Inc is engaged in the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing value of its patent.
General Information
932 Southwood Boulevard
Incline Villiage, NV 89451
www.pdl.com
Industry : Drugs
Sector: Health Care
Employees: 10
CEO: Mr. John P. Mclaughlin
Short Interest
Current Month (Mil) 12.43
Previous Month (Mil) 11.63
Short Interest Ratio (Days) 7.50
Management Effectiveness
Return on Equity 2.00
Return on Assets 1.20
Return on Investments 1.70
Profitability
Gross Margin 95.90
EBIT Margin 26.70
Profit Margin 9.40

Portfolios with PDLI

Latest PDLI Headlines from TheStreet

More Financial News for PDLI

Press Releases for PDLI

See All Press Releases

Partner Headlines for PDLI

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter